Budget Impact Analysis Of Ceftolozane/Tazobactam (Zerbaxa) For The Treatment Of Complicated Intra-Abdominal Infections And Complicated Urinary Tract Infections In The Italian Setting
Abstract
Authors
M Barbieri D Crocchiolo MA Veneziano